Peter Carbone is the Chief Operating Officer at Center for Breakthrough Medicines. He is the former Executive Vice President of Quality and Operations at Acorda Therapeutics and Head of Americas and Special Technologies for Novartis. Peter has over 30 years of Operations, Quality, and Technology leadership experience focused on building out or advancing global capabilities within small to large Pharmaceutical companies including Acorda, Novartis, Amgen, and Bayer. Peter is an accomplished Operations and Quality Executive who has served in multi-billion-dollar companies operating in biotech, pharmaceutical, and medical device markets. He focuses on the strategic buildout of agile, best in class operations, systems, and organizations.
Current role